BAXTER INTERNATIONAL INC — Director's Dealing 2013

Nov 25, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CELL THERAPEUTICS INC (CTIC)
CIK: 0000891293
Period of Report: 2013-11-15

Reporting Person: Baxter Healthcare SA (10% Owner)
Reporting Person: BAXTER INTERNATIONAL INC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series 19 Preferred Stock	$1.914		Common Stock (15673981)		Direct

Footnotes

F1: The 30,000 shares of Series 19 Preferred Stock acquired by the reporting persons are convertible into shares of the Issuer's common stock at any time at the holder's election, and are automatically convertible under certain circumstances but no later than December 15, 2013.

F2: Each share of Series 19 Preferred Stock is convertible at a rate determined by dividing the stated value of each preferred share, which is initially $1,000, by the conversion price of $1.914 per common share.

F3: The reported securities are owned directly by Baxter Healthcare SA, which is an indirect wholly-owned subsidiary of Baxter International Inc. Baxter International Inc. is an indirect beneficial owner of the reported securities.